Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients

NCT04180384 is registered in ClinicalTrials.gov with Athenex, Inc. as lead sponsor.

NCT NCT04180384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04180384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients
Lead sponsor
Athenex, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 23, 2015
Completion date
June 15, 2021
Enrollment
44 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor